News

Latest news

23rd September 2024

SYNERGIA MEDICAL SUCCESSFULLY IMPLANTS FIRST PATIENTS WITH NAO.VNS(TM)

Read more
27th May 2024

東京証券取引所グロース市場への上場承認に関するお知らせ

Read more
15th May 2024

Presentation of the main results of the phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024

Read more
16th April 2024

Acticor Biotech will present the clinical results of its phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024

Read more
22nd March 2024

SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT

Read more
15th March 2024

Acticor Biotech completes a capital increase for a total gross amount of 8 million euros

Read more
26th January 2024

Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure

Read more
26th January 2024

PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions

Read more
4th January 2024

Sequana Medical granted US CPT® III reimbursement codes for alfapump® system

Read more